Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?

In this study we have profiled the free sterol content of cerebrospinal fluid by a combination of charge tagging and liquid chromatography-tandem mass spectrometry. Surprisingly, the most abundant cholesterol metabolites were found to be C-27 and C-24 intermediates of the bile acid biosynthetic pathways with structures corresponding to 7 alpha-hydroxy-3-oxocholest-4-en-26- oic acid (7.170 +/- 2.826 ng/ml, mean +/- S. D., six subjects), 3 beta-hydroxycholest-5-en-26-oic acid (0.416 +/- 0.193 ng/ml), 7 alpha,x-dihydroxy-3-oxocholest-4-en-26-oic acid (1.330 +/- 0.543 ng/ml), and 7 alpha-hydroxy-3-oxochol-4-en-24-oic acid (0.172 +/- k0.085 ng/ml), and the C-26 sterol 7 alpha-hydroxy-26-norcholest-4ene- 3,x-dione (0.204 +/- 0.083 ng/ml), where x is an oxygen atom either on the CD rings or more likely on the C-17 side chain. The ability of intermediates of the bile acid biosynthetic pathways to activate the liver X receptors (LXRs) and the farnesoid X receptor was also evaluated. The acidic cholesterol metabolites 3 beta-hydroxycholest-5-en-26-oic acid and 3 beta,7 alpha-dihydroxycholest-5- en-26-oic acid were found to activate LXR in a luciferase assay, but the major metabolite identified in this study, i.e. 7 alpha-hydroxy-3-oxocholest-4-en-26-oic acid, was not an LXR ligand. 7 alpha-Hydroxy-3-oxocholest-4-en-26-oic acid is formed from 3 beta,7 alpha-dihydroxycholest-5-en-26-oic acid in a reaction catalyzed by 3 beta-hydroxy-Delta(5)-C-27-steroid dehydrogenase (HSD3B7), which may thus represent a deactivation pathway of LXR ligands in brain. Significantly, LXR activation has been found to reduce the symptoms of Alzheimer disease (Fan, J., Donkin, J., and Wellington C. (2009) Biofactors 35, 239-248); thus, cholesterol metabolites may play an important role in the etiology of Alzheimer disease.